TP53 and acute myeloid leukemia: Genes such as TP53, RUNX1, IDH1/2 and FMS-related tyrosine kinase 3 (8), among others, are found to be altered in the different subcategories of AML with prognostic and/or therapeutic implications of utmost importance.